ArticleBiochemistry and biophysics reports2026
Integrated transcriptomic and proteomic validation identifies SLC35D3 as a tumor-selective surface antigen for colorectal and neuroendocrine carcinomas.
Shunsuke Someya et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.